Summary:
A clinical trial study to evaluate the Efficacy and Safety of an investigational product for patients with Plaque psoriasis
Criteria:
1. Able and willing to provide signed informed consent to participate in this study
2. Males or females, age 18-75 years, inclusive, at the Screening Visit
3. Total body weight >40 kg (88 lb)
4. Diagnosis of plaque psoriasis for ≥6 months
5. Plaques covering ≥10% of body surface area (BSA)
6. Psoriasis area severity index score (PASI) score ≥12 and static Physician’s Global Assessment (sPGA) score ≥3
7. Women of childbearing potential (WOCBP) must agree to adhere to highly effective methods of contraception for the entirety of the study and for 30 days after the last dose of study drug
8. Males who are sexually active with WOCBP must agree to use highly effective methods of contraception for the entirety of the study and for 90 days after the last dose of study drug
Qualified Participants May Receive:
If you qualify, you can receive all the drugs related to the study at no cost and can be compensated for your time and travel. No insurance needed!